The epidemiology of acute organ system dysfunction from severe sepsis outside of the intensive care unit.
暂无分享,去创建一个
T. Iwashyna | P. Malani | Lena M. Chen | S. Flanders | C. Bonham | L. Kuhn | Andrew J Odden | Jeffrey M. Rohde
[1] Theodore J Iwashyna,et al. Identifying Patients With Severe Sepsis Using Administrative Claims: Patient-Level Validation of the Angus Implementation of the International Consensus Conference Definition of Severe Sepsis , 2014, Medical care.
[2] Donald M Yealy,et al. Severe sepsis in pre-hospital emergency care: analysis of incidence, care, and outcome. , 2012, American journal of respiratory and critical care medicine.
[3] Fernanda C. Lessa,et al. Current Status of Clostridium difficile Infection Epidemiology , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] M. Büchler,et al. Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trial. , 2012, JAMA.
[5] H. Wunsch,et al. Population Burden of Long‐Term Survivorship After Severe Sepsis in Older Americans , 2012, Journal of the American Geriatrics Society.
[6] T. Rea,et al. Severe Sepsis In Prehospital Emergency Care: Analysis Of Incidence, Care, And Outcome , 2012, ATS 2012.
[7] E. Stranges,et al. Septicemia in U.S. Hospitals, 2009 , 2011 .
[8] R. Munford,et al. Novel therapies for septic shock over the past 4 decades. , 2011, JAMA.
[9] H. Bitterman,et al. Assessment of disease-severity scoring systems for patients with sepsis in general internal medicine departments , 2011, Critical care.
[10] K. Langa,et al. Long-term cognitive impairment and functional disability among survivors of severe sepsis. , 2010, JAMA.
[11] Javier Llorca,et al. Impact of the Surviving Sepsis Campaign protocols on hospital length of stay and mortality in septic shock patients: Results of a three-year follow-up quasi-experimental study* , 2010, Critical care medicine.
[12] J. Dhainaut,et al. Diagnosis and treatment of severe sepsis , 2007, Critical care.
[13] F. Gordo,et al. Sepsis incidence and outcome: Contrasting the intensive care unit with the hospital ward* , 2007, Critical care medicine.
[14] B. Guidet,et al. Incidence and impact of organ dysfunctions associated with sepsis. , 2005, Chest.
[15] V. Sundararajan,et al. Epidemiology of sepsis in Victoria, Australia , 2005, Critical care medicine.
[16] Djillali Annane,et al. Current epidemiology of septic shock: the CUB-Réa Network. , 2003, American journal of respiratory and critical care medicine.
[17] D. Mannino,et al. The epidemiology of sepsis in the United States from 1979 through 2000. , 2003, The New England journal of medicine.
[18] M. Levy,et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference , 2003, Intensive care medicine.
[19] Mitchell M. Levy,et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference , 2003, Intensive Care Medicine.
[20] G. Clermont,et al. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.
[21] George F. Hyman. Vancomycin‐Resistant Enterococci , 1995, Journal of cataract and refractive surgery.
[22] W. Knaus,et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.
[23] H. K. Bourns. Management of Sepsis , 1960, The Medical journal of the South-West.